Xylem (NYSE: XYL) reported Q4 EPS of $0.99, $0.03 better than the analyst estimate of $0.96. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.05 billion.

GUIDANCE:

Xylem sees FY2024 revenue of $8.4-8.5 billion, versus the consensus of $8.42 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.